SUNHO BIO-B Confirms No Share Movements in July 2026; Public Float Remains Compliant

Bulletin Express

Aug 05

Sunho Biologics, Inc. (SUNHO BIO-B) reported that its share capital structure was unchanged for the month ended 31 July 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 5 August 2026.

• Authorised share capital stayed at 200.00 million ordinary shares with a par value of USD 0.0005, equivalent to USD 100,000.

• Issued share capital remained at 156.67 million ordinary shares. The company held no treasury shares at either the beginning or end of the month, and there were no new issues, cancellations, or repurchases.

• Sunho Biologics confirmed compliance with the Main Board’s minimum public float requirement of 25 percent for the reporting period.

• The filing recorded no outstanding share options, warrants, convertible securities, or other arrangements that could dilute existing shareholders.

Chairman and Executive Director Zhang Feng signed the return, reaffirming that the disclosed figures accurately reflect the company’s capital position as of 31 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1145556001"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1145556001\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1145556001?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 17:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1145556001","market":"us","top_or_hot":-1,"title":"SUNHO BIO-B Confirms No Share Movements in July 2026; Public Float Remains Compliant","media":"Bulletin Express","content":"<p>Sunho Biologics, Inc. (SUNHO BIO-B) reported that its share capital structure was unchanged for the month ended 31 July 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 5 August 2026.</p>\n<p>• Authorised share capital stayed at 200.00 million ordinary shares with a par value of USD 0.0005, equivalent to USD 100,000.</p>\n<p>• Issued share capital remained at 156.67 million ordinary shares. The company held no treasury shares at either the beginning or end of the month, and there were no new issues, cancellations, or repurchases.</p>\n<p>• Sunho Biologics confirmed compliance with the Main Board’s minimum public float requirement of 25 percent for the reporting period.</p>\n<p>• The filing recorded no outstanding share options, warrants, convertible securities, or other arrangements that could dilute existing shareholders.</p>\n<p>Chairman and Executive Director Zhang Feng signed the return, reaffirming that the disclosed figures accurately reflect the company’s capital position as of 31 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SUNHO BIO-B Confirms No Share Movements in July 2026; Public Float Remains Compliant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSUNHO BIO-B Confirms No Share Movements in July 2026; Public Float Remains Compliant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 17:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sunho Biologics, Inc. (SUNHO BIO-B) reported that its share capital structure was unchanged for the month ended 31 July 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 5 August 2026.</p>\n<p>• Authorised share capital stayed at 200.00 million ordinary shares with a par value of USD 0.0005, equivalent to USD 100,000.</p>\n<p>• Issued share capital remained at 156.67 million ordinary shares. The company held no treasury shares at either the beginning or end of the month, and there were no new issues, cancellations, or repurchases.</p>\n<p>• Sunho Biologics confirmed compliance with the Main Board’s minimum public float requirement of 25 percent for the reporting period.</p>\n<p>• The filing recorded no outstanding share options, warrants, convertible securities, or other arrangements that could dilute existing shareholders.</p>\n<p>Chairman and Executive Director Zhang Feng signed the return, reaffirming that the disclosed figures accurately reflect the company’s capital position as of 31 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02898","symbol_name":"盛禾生物-B","start_time":0,"source_url":"","article_id":"1145556001","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1145556001","pubTimestamp":1785922205,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sunho Biologics, Inc. (SUNHO BIO-B) reported that its share capital structure was unchanged for the month ended 31 July 2026, according to the company’s monthly return filed with Hong Kong Exchanges...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02898":"盛禾生物-B"},"translate_title":"SUNHO BIO-B 确认 2026 年 7 月股价没有变动；公众持股量保持合规","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02898":1},"content_text":"Sunho Biologics, Inc. (SUNHO BIO-B) reported that its share capital structure was unchanged for the month ended 31 July 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Ltd. on 5 August 2026.\n• Authorised share capital stayed at 200.00 million ordinary shares with a par value of USD 0.0005, equivalent to USD 100,000.\n• Issued share capital remained at 156.67 million ordinary shares. The company held no treasury shares at either the beginning or end of the month, and there were no new issues, cancellations, or repurchases.\n• Sunho Biologics confirmed compliance with the Main Board’s minimum public float requirement of 25 percent for the reporting period.\n• The filing recorded no outstanding share options, warrants, convertible securities, or other arrangements that could dilute existing shareholders.\nChairman and Executive Director Zhang Feng signed the return, reaffirming that the disclosed figures accurately reflect the company’s capital position as of 31 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}